{
    "clinical_study": {
        "@rank": "152918", 
        "brief_summary": {
            "textblock": "To evaluate corneal endothelium cell change after intravitreal Bevacizumab injection"
        }, 
        "brief_title": "Effect of Intravitreal Bevacizumab on Corneal Endothelium", 
        "completion_date": {
            "#text": "October 2013", 
            "@type": "Anticipated"
        }, 
        "condition": "Corneal Endothelial Cell Loss", 
        "condition_browse": {
            "mesh_term": "Corneal Endothelial Cell Loss"
        }, 
        "detailed_description": {
            "textblock": "Intravitreal Bevacizumab has been used by retinal specialist in treatment many retinal\n      diseases. Although it not approved by FDA for treatment. In many In vitro studies, its\n      showed saftey in the eyes especially for corneal endothelium cells, that important cells to\n      keep cornea clear. This study use Confoscan-Corneal confocal microsope to evaluate corneal\n      endothelium before and after intravitreal Bevacizumab injection in routine retinal disease\n      at 6 month follow up."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  aged between 20 and 80 years old\n\n          -  can come to regular follow up at 6 month\n\n          -  signed written consent forms\n\n          -  not have corneal scar, or glaucoma\n\n          -  history of treatment with laser or anti-VEGF therapy in 3 month prior to recruit\n\n          -  high risk in cerebrovascular and cardiovascular diseases\n\n          -  Pregnancy and breastfeeding\n\n          -  can undergo confocal microspopy\n\n        Exclusion Criteria:\n\n          -  History of intraocular surgery or ocular trauma during study"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "80 Years", 
            "minimum_age": "18 Years", 
            "sampling_method": "Non-Probability Sample", 
            "study_pop": {
                "textblock": "Patient in retinalvascular clinic with diagnosis of retinal vein occlusion with macular\n        edema, diabetic macular edema, wet aged related macular degeneration and submacular\n        hemorrhage)treated with intravitreal Bevacizumab"
            }
        }, 
        "enrollment": {
            "#text": "37", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "November 11, 2012", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01726790", 
            "org_study_id": "HE541020"
        }, 
        "intervention_browse": {
            "mesh_term": "Bevacizumab"
        }, 
        "is_fda_regulated": "No", 
        "keyword": [
            "corneal endothelium", 
            "Bevacizumab", 
            "Intravitreal injection", 
            "Confoscan"
        ], 
        "lastchanged_date": "November 11, 2012", 
        "location": {
            "contact": {
                "email": "yosanan@kku.ac.th", 
                "last_name": "Yosanan Yospaiboon, Professor", 
                "phone": "6643363010"
            }, 
            "facility": {
                "address": {
                    "city": "Khon kaen", 
                    "country": "Thailand", 
                    "zip": "4002"
                }, 
                "name": "KKU eye center, department of Ophthalmolgy, faculty of medicine, khon kaen university"
            }, 
            "investigator": {
                "last_name": "Kasem Yospaiboon, MD", 
                "role": "Principal Investigator"
            }, 
            "status": "Recruiting"
        }, 
        "location_countries": {
            "country": "Thailand"
        }, 
        "number_of_groups": "1", 
        "official_title": "Effect of Intravitreal Bevacizumab on Corneal Endothelium", 
        "overall_contact": {
            "email": "kasem_yod@hotmail.com", 
            "last_name": "Kasem Yospaiboon, MD", 
            "phone": "66823057231"
        }, 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "Thailand: Khon Kaen University Ethics Committee for Human Research", 
            "has_dmc": "Yes"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "June 2013", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "description": "Measure the corneal endothelium cell using Confoscan4-Corneal confocal microscope in patient in retinal vascular clinic before and after treat with intravitreal Bevacizumab", 
            "measure": "Corneal endothelium cell change after intravitreal Bevacizumab injection", 
            "safety_issue": "Yes", 
            "time_frame": "6 months"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01726790"
        }, 
        "responsible_party": {
            "investigator_affiliation": "Khon Kaen University", 
            "investigator_full_name": "Kasem Yospaiboon", 
            "investigator_title": "Kasem Yospaiboon, MD", 
            "responsible_party_type": "Principal Investigator"
        }, 
        "secondary_outcome": {
            "measure": "Assess the complication after intravitreal Bevacizumab injection", 
            "safety_issue": "Yes", 
            "time_frame": "6 month"
        }, 
        "source": "Khon Kaen University", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Khon Kaen University", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "August 2011", 
        "study_design": "Observational Model: Case-Only, Time Perspective: Prospective", 
        "study_type": "Observational", 
        "verification_date": "November 2012"
    }
}